Clinical Pharmacy: A Comprehensive Review for Improving Patient Care
Abstract
By seamlessly integrating pharmacological knowledge into healthcare teams, clinical pharmacy has revolutionised patient care. This in-depth analysis examines the dynamic environment of clinical pharmacy, tracing its development, defining responsibilities, resolving difficulties, imagining potential outcomes. The thorough history of clinical pharmacy’s transition from medication dispensing to patient-centered care highlights the critical role that clinical pharmacy plays in advancing pharmaceutical therapy.
The responsibilities of clinical pharmacists nowadays are broad, including drug reconciliation, therapeutic monitoring, pharmacotherapy optimisation, patient counselling, group decision-making. These obligations enable patients to actively participate in their treatment while also ensuring the safety and effectiveness of medications.
Clinical chemists use their knowledge to proactively detect and manage risks as alert watchdogs against pharmaceutical errors and adverse events, enhancing patient safety. A core component of clinical pharmacy, pharmacotherapy optimisation, adapts treatment regimens to specific patients while taking into account a variety of variables that affect medication response.
Clinical chemists also fill in the gaps created by care transitions, maintaining continuity through careful medication reconciliation, patient education, improved communication between healthcare institutions.
Clinical pharmacy still faces integration and professional development issues in spite of forward progress. Advocating for policy recognition and embracing technical improvements are two ways to get beyond these obstacles and increase the field’s influence. Future success for clinical pharmacy depends on its ability to embrace innovation, promote interprofessional cooperation, adjust to changing patient demands.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Journal of Drug Discovery and Development ( ISSN:2581-6861)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
We, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-
1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.
2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.
3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.
5. I/We also agree to the authorship of the article in the following sequence:-
Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________
Important
(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.
(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.
(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.